Литература

Поставить закладку

Белобородов В.Б., Гусаров В.Г., Дехнич А.В., Замятин М.Н., Зубарева Н.А., Зырянов С.К., Камышова Д.А., Климко Н.Н., Козлов Р.С., Кулабухов В.В., Полушин Ю.С., Руднов В.А., Сидоренко С.В., Шлык И.В., Эдельштейн М.В., Яковлев С.В. Диагностика и антимикробная терапия инфекций, вызванных полирезистентными микроорганизмами. Методические рекомендации. / / Вестник анестезиологии и реаниматологии. - 2020. - Т. 17, № 1. - С. 52-83. DOI: 10.21292/2078-5658-2020-17-1-52-83.
Гусаров В.Г., Лашенкова Н.Н., Петрова Н.В. и др. Протоколы эмпирической антимикробной терапии как инструмент улучшения качества неотложной медицинской помощи пациентам с инфекцией в многопрофильном хирургическом стационаре // Медицинский алфавит. – 2016. – Т. 33, № 4. – Неотложная медицина. – С. 28–24.
Диагностика и лечение микозов в отделениях реанимации и интенсивной терапии: Российские рекомендации / Отв. ред. Н.Н. Климко. – 2-е изд. доп. и перераб. – М.: Фармтек, 2015. – 96 с.
Карпов О.Э., Гусаров В.Г., Замятин М.Н., Орлова О.А., Петрова Л.В., Камышова Д.А., Дементиенко М.В., Габоян Я.С., Пивкина А.И., Гриценко Е.А. Управление антибиотикорезистентностью в стационаре: современные реалии и перспективы // Клиническая микробиология и антимикробная химиотерапия. – 2020. – Т. 22. - № 4. – С. 277-286. DOI: 10.36488/cmac.2020.4.277-286.
Найговзина Н.В., Попова А.Ю., Бирюкова Е.Е. и др. Оптимизация системы мер борьбы и профилактики инфекций, связанных с оказанием медицинской помощи в Российской Федерации // ОРГЗДРАВ: Новости. Мнения. Обучение. Вестник ВШОУЗ. – 2018. – №. 1 (11). – C. 17-26. https://epidemiology-journal.ru/ru/archive/article/36040
Определение чувствительности к антимикробным препаратам. Клинические рекомендации //Интернет- портал главного внештатного специалиста Минздрава России по клинической микробиологии и антимикробной резистентности. - https://www.antibiotic.ru/files/321/clrec-dsma2021.pdf
План мероприятий на 2019 – 2024 годы по реализации Стратегии предупреждения распространения антимикробной резистентности в Российской Федерации на период до 2030 года. Утвержден распоряжением Правительства Российской Федерации от 30 марта 2019 г. № 604-р. https://www.garant.ru/products/ipo/prime/doc/71677266/
Попов Д. А. Сравнительная характеристика современных методов определения продукции карбапенемаз / Попов Д. А. // Клиническая микробиология и антимикробная химиотерапия. – 2019. – Т. 21. – №. 2 – С.125-133.
Практическое руководство по мониторингу антибиотикорезистентности с использованием платформы AMRcloud» https://monitoring.amrcloud.net/docs
Программа СКАТ (Стратегия Контроля Антимикробной Терапии) при оказании стационарной медицинской помощи: Российские клинические рекомендации /Под ред. С.В. Яковлева, Н.И. Брико, С.В. Сидоренко и др. – М.: Издательство «Перо», 2018. – 156 с.
Романов А.В., Дехнич А.В., Сухорукова М.В. и др. Антибиотикорезистентность нозокомиальных штаммов в стационарах России: результаты многоцентрового эпидемиологического исследования МАРАФОН в 2015-2016 г. // Клиническая микробиология и антимикробная химиотерапия. – 2019. – Т. 21. – С. 147- 159.
Штейнберг Л.Л., Упницкий А.А., Белоусов Ю.Б. Особенности применения карбапенемов в лечении нозокомиальной пневмонии // Лечебное дело. – 2014. – № 1. – C. 27-32.
Яковлев С.В., Суворова М.П., Белобородов В.Б., с соавт. Распространённость и клиническое значение нозокомиальных инфекций в лечебных учреждениях России: исследование ЭРГИНИ // Антибиотики и химиотерапия. – 2016. – Т. 61. – С. 5-6.
Aaftab G.P., Patil A.B., Medegar S. Multivariate analysis of risk factors for ESBL and AmpC producing Escherichia coli and Klebsiella pneumoniae at a Tertiary Care Hospital in Karnataka: A case control study // Indian Journal of Microbiology Research. – 2018. – Vol. 5, № 1. – P. 1-6. doi:10.18231/2394-5478.2018.0001
Aloush V., Navon-Venezia, S., Seigman-Igra Y. et al. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact // Antimicrobial agents and chemotherapy. – 2006. – Vol. 50, №1. – P. 43-48. doi:10.1128/AAC.50.1.43-48.2006
Ashley C., Dunleavy A. The renal drug handbook: the ultimate prescribing guide for renal practitioners. 5th edition. CRC Press Taylor & Francis Group, 2019 Paperback: 1108 pp. – ISBN-10: 9781138624511
Bassetti M., Righi E. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections // Current opinion in critical care. – 2015. – Vol. 21, №. 5. – P. 402-411. doi: 10.1097/MCC.0000000000000235
Bassetti M., Righi E., Carnelutti A. Bloodstream infections in the intensive care unit // Virulence. – 2016. – Vol. 7, № 3. – P. 267-279. doi: 10.1080/21505594.2015.1134072
Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure // Antimicrobial agents and chemotherapy. – 1995. – Vol. 39, №. 6. – P. 1211- 1233. doi: 10.1128/AAC.39.6.1211
Callejo-Torre F., Bouza J.M.E., Astigarraga P.O. et al. Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU ad- mission // Europe. – 2016. – Vol. 5. – P. 1-9. PMID: 27668900
Cao B., Wang H., Sun H., et al. Risk factors and clinical outcomes of nosocomial multidrug resistant Pseudomonas aeruginosa infections // Journal of Hospital Infection. – 2004. – Vol. 57, № 2. – P. 112-118. doi:10.1016/j.jhin.2004.03.021
Cornely O., Alastruey-Izquierdo A., Arenz D. et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium // The Lancet Infect Dis. – 2019. – Vol. 12. – e405-e421 doi: 10.1016/S1473-3099(19)30312-3
De Pascale G., Montini L., Pennisi M.A. et al. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria // Critical Care. – 2014. – Vol. 18, № 3. – R90. doi:10.1186/cc13858
Dellit T.H. Owens R.C., McGowan J.E. et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship // Clinical Infectious Diseases. – 2007. – Vol. 44, № 2. – P. 159-177. doi: 10.1086/510393
Doumith M., Ellington M.J., Livermore D.M. et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK // Journal of Antimicrobial Chemotherapy. – 2009. – Vol. 63, № 4. – P. 659-667. doi: 10.1093/jac/dkp029
Doyle D., Peirano G., Lascols C. et al. Laboratory detection of Enterobacteriaceae that produce carbapenemases // Journal of clinical microbiology. – 2012. – Vol. 50, №. 12. – P. 3877-3880. doi: 10.1128/JCM.02117-12
Evans L., Rhodes A., Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2021 // Intensive Care Med. – 2021. – Vol. 47, №11. – P. 1181-1247. doi.org/10.1007/s00134-021-06506-y
Duin D., Arias C. A., Komarow L., Chen L. et al. Molecular and clinical epidemiology of carbapenemresistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study // The Lancet Infectious Diseases.- 2020.- Vol. 20.- № 6.- P. 731-741. doi: 10.1016/S1473-3099(19)30755-8
European Centres for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2011. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2011
Falcone M., Russo A., Venditti M. et al. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia // Clinical infectious diseases. – 2013. – Vol. 57, № 11. – P. 1568-1576. doi:10.1093/cid/cit582
Gazin M., Lammens, C., Goossens, H. et al. Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci // European journal of clinical microbiology & infectious diseases. – 2012. – Vol. 31, № 3. – P. 273-276. doi: 10.1007/s10096-011-1306-y
Ghibu L., Miftode E., Teodor A. et al. Risk factors for Pseudomonas aeruginosa infections, resistant to carbapenem // Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. – 2010. – Vol. 114, № 4. – P. 1012-1016. PMID: 21500452
Giske C.G., Gezelius L., Samuelsen O. et al. A sensitive and specific phenotypic assay for detection of metallo‐β‐lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin // Clinical microbiology and infection. – 2011. – Vol. 17, № 4. – P. 552-556. doi: 10.1111/j.1469-0691.2010.03294.x.
Gniadkowski M. Evolution of extended‐spectrum β‐lactamases by mutation // Clinical microbiology and infection. – 2008. – Vol. 14. – P. 11-32. doi.org/10.1111/j.1469-0691.2007.01854.x
Gomez F., Veita J., Laudanski K. Antibiotics and ECMO in the Adult Population - Persistent Challenges and Practical Guides//Antibiotics.-2022.- №11, 338. https:// doi.org/10.3390/antibiotics11030338
Goyal D., Dean N., Neill S., et al. Risk Factors for community-acquired extended-spectrum beta-lactamase-producing enterobacteriaceae infections – a retrospective study of symptomatic urinary tract infections // Open forum infectious diseases. – US: Oxford University Press, 2019. – Vol. 6. – № 2. doi.org/10.1093/ofid/ofy357
Grabein B., Graninger W., Baño J. et al. Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature // Clinical Microbiology and Infection. – 2017. – Vol. 23. – №. 6. – P. 363-372. doi: 10.1016/j.cmi.2016.12.005
Greissl C., Saleh A., Hamprecht A. Rapid detection of OXA-48-like, KPC, NDM, and VIM carbapenemases in Enterobacterales by a new multiplex immunochromatographic test / Greissl C., Saleh A., Hamprecht A. // European Journal of Clinical Microbiology & Infectious Diseases. – 2019. – Vol. 38. – №. 2. – P. 331-335. doi: 10.1007/s10096-018-3432-2
Haley C.C., Mittal D., LaViolette A., et al. Methicillin-resistant Staphylococcus aureus infection or colonization present at hospital admission: multivariable risk factor screening to increase efficiency of surveillance culturing // Journal of clinical microbiology. – 2007. – Vol. 45, № 9. – P. 3031-3038. doi: 10.1128/JCM.00315-07
Hahn J., Choi J.H., Chang M.J. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. J Clin Pharm Ther. 2017; 42: 661– 671. https://doi.org/10.1111/jcpt.12636
Hovan M. R., Narayanan N., Cedarbaum V., Bhowmick T., Kirn T. J. Comparing Mortality in Patients with Carbapenemase-Producing Carbapenem Resistant Enterobacterales and non-Carbapenemase-Producing Carbapenem Resistant Enterobacterales Bacteremia // Diagnostic Microbiology and Infectious Disease.- 2021.- P. 115505. doi: 10.1016/j.diagmicrobio.2021.115505
Kao K.C., Chen C.B., Hu H.C. et al. Risk factors of methicillin-resistant Staphylococcus aureus infection and correlation with nasal colonization based on molecular genotyping in medical intensive care units: a prospective observational study // Medicine. – 2015. – Vol. 94, № 28. – e1100. doi: 10.1097/MD.0000000000001100.
Merchant S., Proudfoot E.M., Quadri H.N. et al. Risk factors for Pseudomonas aeruginosa infections in AsiaPacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis // Journal of global antimicrobial resistance. – 2018. – Vol. 14. – P. 33-44. doi: 10.1016/j.jgar.2018.02.005
Nicolas-Chanoine M.H., Vigan M., Laouenan C. et al. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study // European Journal of Clinical Microbiology & Infectious Diseases. – 2019. – Vol. 38, № 2. – P. 383-393. doi: 10.1007/s10096-018-3438-9.
Ohmagari N., Hanna H., Graviss L. et al. Risk factors for infections with multidrug‐resistant Pseudomonas aeruginosa in patients with cancer // Cancer. – 2005. – Vol. 104, №. 1. – P. 205-212. doi: 10.1002/cncr.21115
Pappas P.G., Kauffman C.A., Andes D.R. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America // Clinical Infectious Diseases. – 2016. –Vol. 62. – e1–50. doi: 10.1093/cid/civ933
Paul M., Carrara E., Retamar P. et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)// Clinical Microbiology and Infection, https://doi.org/10.1016/j.cmi.2021.11.025
Platteel T.N., Stuart J.C., Voets G.M. et al. Evaluation of a commercial microarray as a confirmation test for the presence of extended‐spectrum β‐lactamases in isolates from the routine clinical setting // Clinical Microbiology and Infection. – 2011. – Vol. 17, № 9. – P. 1435-1438. doi: 10.1111/j.1469-0691.2011.03567.x.
Predic M., Delano J.P., Tremblay E. et al. Risk factors for carbapenem-resistant Enterobacteriaceae infection // American Journal of Infection Control. – 2017. – Vol. 45, № 6. – P. S14. doi: doi.org/10.1016/j.ajic.2017.04.271
Queenan A.M., Bush K. Carbapenemases: the versatile β-lactamases // Clinical microbiology reviews. – 2007. – Vol. 20, №. 3. – P. 440-458. doi: 10.1128/CMR.00001-07
Red Book. 29 Edition; American Academy of Pediatrics. – 2012. 1058 pp. ISBN-10: 158110703X
Rybak M.J, Pharm D., Le J. et al. Therapeutic monitoring of Vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists // American Journal of Health-System Pharmacy. – 2020. – Vol. 77, Is. 11. – P. 835–864. https://doi.org/10.1093/ajhp/zxaa036
Sfeir M.M., Hayden J.A., Fauntleroy K.A. et al. EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing Enterobacteriaceae // Journal of clinical microbiology. – 2019. – Vol. 57, № 5. doi:10.1128/JCM.01757-18.
Søraas A., Sundsfjord A., Sandven I. et al. Risk factors for community-acquired urinary tract infections caused by ESBL-producing Enterobacteriaceae-a case-control study in a low prevalence country // PloS one. – 2013. – Vol. 8, № 7. – e 69581. doi:10.1371/journal.pone.0069581.
Taccone F.S., Laterre P.F., Spapen H. et al. Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock // Critical care. – 2010. – Vol. 14. – №. 2. – P. R53. doi.org/10.1093/cid/ciq146
The Sanford Guide to Antimicrobial Therapy 2014. 44 Edition. 243 pp. ISBN-10: 1930808801
Tuon F.F., Kruger M., Terreri M. et al. Klebsiella ESBL bacteremia-mortality and risk factors // Brazilian Journal of Infectious Diseases. – 2011. – Vol. 15, № 6. – P. 594-598. doi: 10.1590/s1413- 86702011000600016
Udy A.A., Baptista J.P., Lim N.L. et al. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations // Critical care medicine. – 2014. – Vol. 42, № 3. – P. 520-527. doi: 10.1097/CCM.0000000000000029
Ullmann A.J., Aguado J.M., Arikan-Akdagli S. et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline // Clin Microbiol Infect. – 2018. – Vol. 24 (Suppl 1). – e1-e38. doi: 10.1016/j.cmi.2018.01.002.
Vading M., Samuelsen Ø., Haldorsen B. et al. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems // Clinical Microbiology and Infection. – 2011. – Vol. 17, № 5. – P. 668-674. doi: 10.1111/j.1469-0691.2010.03299.x
Van der Zwaluw K., de Haan A., Pluister G.N. et al. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods // PloS one. – 2015. – Vol. 10, № 3. – P. e0123690. doi: 10.1371/journal.pone.0123690
Van Dijk K., Voets G.M., Scharringa J. et al. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin // Clinical Microbiology and Infection. – 2014. – Vol. 20, № 4. – P. 345-349. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60285-8/pdf
Wener K.M., Schechner V., Gold H.S. et al. Treatment with fluoroquinolones or with β-lactam-β-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-β-lactamase-producing Klebsiella species in hospitalized patients // Antimicrobial agents and chemotherapy. – 2010. – Vol. 54, № 5. doi:10.1128/AAC.01131-09.
WHO: Antimicrobial resistance: global report on surveillance, 2014. https://apps.who.int/iris/handle/10665/112642
Willemsen I., Overdevest I., al Naiemi N. et al. New diagnostic microarray (Check-KPC ESBL) for detection and identification of extended-spectrum beta-lactamases in highly resistant Enterobacteriaceae // Journal of clinical microbiology. – 2011. – Vol. 49. – №. 8. – P. 2985-2987. doi: 10.1128/JCM.02087-10.
Yu Z., Pang X., Wu X. et al. Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis // PloS one. – 2018. – Vol. 13, № 7. – e0201667. doi: 10.1371/journal.pone.0201667
Zaha D.C., Kiss R., Hegedűs C. et al. Recent advances in investigation, prevention, and management of healthcare-associated infections (hais): resistant multidrug strain colonization and its risk factors in an Intensive Care Unit of a University Hospital // BioMed Research International. – 2019. doi: 10.1155/2019/2510875.
Zamyatin M., Gusarov V., Petrova N. et al. Results of antimicrobial stewardship programme implementation in multidisciplinary hospital // ICU Management & Practice. 2018 – Vol. 18. – №2. – P. 125-127. https://healthmanagement.org/c/icu/issuearticle/results-of-antimicrobial-stewardship-programme-implementation-in-multidisciplinary-hospitai